Cargando…

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial

Rationale: Targeted lung denervation (TLD) is a bronchoscopic radiofrequency ablation therapy for chronic obstructive pulmonary disease (COPD), which durably disrupts parasympathetic pulmonary nerves to decrease airway resistance and mucus hypersecretion. Objectives: To determine the safety and impa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slebos, Dirk-Jan, Shah, Pallav L., Herth, Felix J. F., Pison, Christophe, Schumann, Christian, Hübner, Ralf-Harto, Bonta, Peter I., Kessler, Romain, Gesierich, Wolfgang, Darwiche, Kaid, Lamprecht, Bernd, Perez, Thierry, Skowasch, Dirk, Deslee, Gaetan, Marceau, Armelle, Sciurba, Frank C., Gosens, Reinoud, Hartman, Jorine E., Srikanthan, Karthi, Duller, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909835/ https://www.ncbi.nlm.nih.gov/pubmed/31404499 http://dx.doi.org/10.1164/rccm.201903-0624OC

Ejemplares similares

Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
por: Valipour, Arschang, et al.
Publicado: (2020)

Targeted lung denervation modulates the mucosal epithelial transcriptome in COPD
por: Srikanthan, Karthi, et al.
Publicado: (2022)

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)
por: Slebos, Dirk-Jan, et al.
Publicado: (2020)

Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
por: Christophe, Pison, et al.
Publicado: (2021)

Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
por: Pison, Christophe, et al.
Publicado: (2021)

Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction
por: Hartman, Jorine E., et al.
Publicado: (2020)

Bronchoscopic Lung Volume Reduction Coil Treatment for Severe Emphysema: A Systematic Review and Meta-Analysis of Individual Participant Data
por: Roodenburg, Sharyn A., et al.
Publicado: (2022)

New bronchoscopic treatment modalities for patients with chronic bronchitis
por: Hartman, Jorine E., et al.
Publicado: (2021)

Long-term safety of bilateral targeted lung denervation in patients with COPD
por: Valipour, Arschang, et al.
Publicado: (2018)

Lung volume reduction in real clinical practice
por: Hartman, Jorine E., et al.
Publicado: (2021)

Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
por: Deslee, Gaëtan, et al.
Publicado: (2014)

Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severity
por: Perotin, Jeanne-Marie, et al.
Publicado: (2014)

The impact of emphysema heterogeneity on treatment response after endobronchial valve treatment
por: Roodenburg, Sharyn A., et al.
Publicado: (2023)

Bronchial Thermoplasty Global Registry (BTGR): 2-year results
por: Torrego, Alfons, et al.
Publicado: (2021)

Minimal important difference of change in patient-specific goals in severe emphysema patients
por: Hartman, Jorine E., et al.
Publicado: (2020)

Prevalence and Impact of COVID-19 among Severe COPD Patients post Bronchoscopic Lung Volume Reduction Treatment with Endobronchial Valves
por: Klooster, Karin, et al.
Publicado: (2022)

A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD
por: Garner, Justin L., et al.
Publicado: (2020)

Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema
por: Hartman, Jorine E, et al.
Publicado: (2015)

Change in Dynamic Hyperinflation After Bronchoscopic Lung Volume Reduction in Patients with Emphysema
por: van Dijk, Marlies, et al.
Publicado: (2020)

Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency
por: Everaerts, Stephanie, et al.
Publicado: (2023)

Airflow Obstruction and Cardio-metabolic Comorbidities
por: Triest, Filip J.J., et al.
Publicado: (2019)

Seeing the world through different lenses: activity registration differs between two validated accelerometers
por: van der Molen, Marieke C., et al.
Publicado: (2020)

Revision Bronchoscopy After Endobronchial Valve Treatment for Emphysema: Indications, Findings and Outcomes
por: Roodenburg, Sharyn A, et al.
Publicado: (2021)

Response to endobronchial valve treatment: it's all about the target lobe
por: Hartman, Jorine E., et al.
Publicado: (2023)

Lung Cancer Surgery after Neoadjuvant Immunotherapy
por: Stefani, Dirk, et al.
Publicado: (2021)

Endobronchial valves for severe emphysema
por: Hartman, Jorine E., et al.
Publicado: (2019)

Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema
por: Hartman, Jorine E., et al.
Publicado: (2022)

Endobronchial valves for emphysema: an individual patient-level reanalysis of randomised controlled trials
por: Klooster, Karin, et al.
Publicado: (2017)

New Spirometry Indices for Detecting Mild Airflow Obstruction
por: Bhatt, Surya P., et al.
Publicado: (2018)

Comparison of Multiple Diagnostic Tests to Measure Dynamic Hyperinflation in Patients with Severe Emphysema Treated with Endobronchial Coils
por: van Dijk, Marlies, et al.
Publicado: (2021)

The effects of lung volume reduction treatment on diffusing capacity and gas exchange
por: van Dijk, Marlies, et al.
Publicado: (2020)

Elevated N-Terminal Pro-Brain Natriuretic Peptide Is Associated with Mortality in Tobacco Smokers Independent of Airflow Obstruction
por: Stamm, Jason A., et al.
Publicado: (2011)

Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes
por: de Weger, Wouter W., et al.
Publicado: (2020)

Cholinergic Regulation of Airway Inflammation and Remodelling
por: Kolahian, Saeed, et al.
Publicado: (2012)

WNT-5A: signaling and functions in health and disease
por: Kumawat, Kuldeep, et al.
Publicado: (2015)

The mode of action of anticholinergics in asthma
por: Gosens, Reinoud, et al.
Publicado: (2018)

Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease – a prospective, randomized, multicentre cross-over trial
por: Hetzel, Juergen, et al.
Publicado: (2019)

The nodule in the emphysematous lung: an appeal for surgery in a lung volume reduction concept
por: Plönes, Till, et al.
Publicado: (2023)

An Integrative Approach of the Fissure Completeness Score and Chartis Assessment in Endobronchial Valve Treatment for Emphysema
por: Klooster, Karin, et al.
Publicado: (2020)

Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation
por: Shah, Pallav L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8bnagd93tkqeu52fvl6itjqbbo